Insider Trading & Ownership - Gerberding Julie L.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Gerberding Julie L.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-01
Sale
2021-11-03
4:11 pm
Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer
96,270$87.91$8,462,68271,691
(Direct)
View
2020-07-17
Sale
2020-07-20
4:53 pm
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
36,285$80$2,902,97626,577
(Direct)
View
2020-01-13
Sale
2020-01-15
5:15 pm
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
102,073$89.34$9,118,86537,038
(Direct)
View
2019-08-22
Sale
2019-08-23
4:11 pm
CERNER CorpCERNGerberding Julie L.
Director
7,928$71.82$569,3898,128
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-07
Option Award
2023-06-09
6:41 pm
N/A
2033-06-06
HilleVax Inc.HLVXGerberding Julie L.
Director
22,500$022,500
(Direct)
View
2022-08-19
Option Award
2022-08-23
4:36 pm
N/A
2032-08-18
HilleVax Inc.HLVXGerberding Julie L.
Director
25,000$025,000
(Direct)
View
2022-06-07
Equity Swap
2022-06-09
5:24 pm
N/A
N/A
CERNER CorpCERNGerberding Julie L.
Director
15,032$950
(Direct)
View

Ownership
2022-04-28
9:45 pm
N/A
N/A
HilleVax Inc.HLVXGerberding Julie L.
Director
0$042,025
(Direct)
View
2022-02-24
Option Award
2022-02-28
4:17 pm
N/A
N/A
Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer
9,550$73.5148,712
(Direct)
View
2021-11-01
Exercise
2021-11-03
4:11 pm
2018-05-05
2027-05-04
Merck & Co. Inc.MRKGerberding Julie L.
EVP, Chief Patient Officer
96,270$071,691
(Direct)
View

Ownership
2021-08-11
8:16 pm
N/A
N/A
AfterNext HealthTech Acquisition Corp.AFTRGerberding Julie L.
Director
0$040,000
(Direct)
View
2021-05-19
Option Award
2021-05-20
5:29 pm
N/A
N/A
CERNER CorpCERNGerberding Julie L.
Director
3,188$015,032
(Direct)
View
2021-05-04
Option Award
2021-05-06
4:43 pm
2022-05-04
2031-05-03
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
39,796$078,958
(Direct)
View
2021-02-26
Option Award
2021-03-02
11:46 am
N/A
N/A
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
12,585$72.6239,162
(Direct)
View
2020-07-17
Exercise
2020-07-20
4:53 pm
2017-05-10
2026-05-09
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
18,111$026,577
(Direct)
View
2020-05-22
Option Award
2020-05-27
4:12 pm
N/A
N/A
CERNER CorpCERNGerberding Julie L.
Director
3,716$011,844
(Direct)
View
2020-05-01
Option Award
2020-05-05
4:45 pm
2021-05-01
2030-04-30
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
33,226$077,977
(Direct)
View
2020-02-28
Option Award
2020-03-03
5:30 pm
N/A
N/A
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
7,371$76.5644,409
(Direct)
View
2020-01-13
Exercise
2020-01-15
5:15 pm
2016-05-01
2025-04-30
Merck & Co. Inc.MRKGerberding Julie L.
EVP Strat Comm, GI Pub Policy
82,548$037,038
(Direct)
View
2019-05-30
Option Award
2019-06-03
4:10 pm
N/A
N/A
CERNER CORPCERNGerberding Julie L.
Director
3,556$016,056
(Direct)
View